Pilongo, Rudilyn T.

HRN: 26-64-10  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/22/2025
CEFUROXIME 1.5GM (VIAL)
03/22/2025
03/26/2025
IV
1.5gms
Q8hrs X 5 Days
S/P STAT CS With BTL
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: